Bicyclic amines as CDK2 inhibitors
US11851426B2 · kind B2 · utility
2Cited by
26References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2020 |
| Grant date | Dec 26, 2023 |
| Priority date | — |
| Expiry date | Jan 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides bicyclic amines that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.